Assessing the Sensitivity of Treatment Effect Estimates to Differential Follow-Up Rates: Implications for Translational Research
- PMID: 22956890
- PMCID: PMC3433078
- DOI: 10.1007/s10742-012-0089-7
Assessing the Sensitivity of Treatment Effect Estimates to Differential Follow-Up Rates: Implications for Translational Research
Abstract
We develop a new tool for assessing the sensitivity of findings on treatment effectiveness to differential follow-up rates in the two treatment conditions being compared. The method censors the group with the higher response rate to create a synthetic respondent group that is then compared with the observed cases in the other condition to estimate a treatment effect. Censoring is done under various assumptions about the strength of the relationship between follow-up and outcomes to determine how informative differential dropout can alter inferences relative to estimates from models that assume the data are missing at random. The method provides an intuitive measure for understanding the strength of the association between outcomes and dropout that would be required to alter inferences about treatment effects. Our approach is motivated by translational research in which treatments found to be effective under experimental conditions are tested in standard treatment conditions. In such applications, follow-up rates in the experimental setting are likely to be substantially higher than in the standard setting, especially when observational data are used in the evaluation. We test the method on a case study evaluation of the effectiveness of an evidence-supported adolescent substance abuse treatment program (Motivational Enhancement Therapy/Cognitive Behavioral Therapy-5 [MET/CBT-5]) delivered by community-based treatment providers relative to its performance in a controlled research trial. In this case study, follow-up rates in the community based settings were extremely low (54%) compared to the experimental setting (95%) giving raise to concerns about non-ignorable drop-out.
Figures


Similar articles
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Impact of missing data due to drop-outs on estimators for rates of change in longitudinal studies: a simulation study.Stat Med. 2001 Dec 30;20(24):3715-28. doi: 10.1002/sim.1114. Stat Med. 2001. PMID: 11782028
-
Comparative Effectiveness of Group-Delivered Acceptance and Commitment Therapy versus Cognitive Behavioral Therapy for Smoking Cessation: A Randomized Controlled Trial.Nicotine Tob Res. 2020 Mar 16;22(3):354-362. doi: 10.1093/ntr/nty268. Nicotine Tob Res. 2020. PMID: 30590810 Free PMC article. Clinical Trial.
-
Dropout from cognitive-behavioral therapy for eating disorders: A meta-analysis of randomized, controlled trials.Int J Eat Disord. 2018 May;51(5):381-391. doi: 10.1002/eat.22850. Epub 2018 Mar 1. Int J Eat Disord. 2018. PMID: 29493805 Review.
-
Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis.JAMA Netw Open. 2020 Jun 1;3(6):e208279. doi: 10.1001/jamanetworkopen.2020.8279. JAMA Netw Open. 2020. PMID: 32558914 Free PMC article.
Cited by
-
Comparative effectiveness of individual versus family-based substance use treatment on adolescent self-injurious thoughts and behaviors.J Subst Abuse Treat. 2022 Aug;139:108782. doi: 10.1016/j.jsat.2022.108782. Epub 2022 Apr 16. J Subst Abuse Treat. 2022. PMID: 35461747 Free PMC article.
-
Association Between Process-Based Quality Indicators and Mortality for Patients With Substance Use Disorders.J Stud Alcohol Drugs. 2017 May;78(4):588-596. doi: 10.15288/jsad.2017.78.588. J Stud Alcohol Drugs. 2017. PMID: 28728641 Free PMC article.
-
Association between process measures and mortality in individuals with opioid use disorders.Drug Alcohol Depend. 2017 Aug 1;177:307-314. doi: 10.1016/j.drugalcdep.2017.03.033. Epub 2017 Jun 27. Drug Alcohol Depend. 2017. PMID: 28662975 Free PMC article.
-
Association Between Quality Measures and Mortality in Individuals With Co-Occurring Mental Health and Substance Use Disorders.J Subst Abuse Treat. 2016 Oct;69:1-8. doi: 10.1016/j.jsat.2016.06.001. Epub 2016 Jun 7. J Subst Abuse Treat. 2016. PMID: 27568504 Free PMC article.
-
Expanding outcomes when considering the relative effectiveness of two evidence-based outpatient treatment programs for adolescents.J Subst Abuse Treat. 2020 Nov;118:108075. doi: 10.1016/j.jsat.2020.108075. Epub 2020 Jul 6. J Subst Abuse Treat. 2020. PMID: 32972649 Free PMC article.
References
-
- Alford GS, Koehler RA, Leonard J. Alcoholics Anonymous-Narcotics Anonymous model inpatient treatment of chemically dependent adolescents: A 2-year outcome study. J Stud Alcohol. 1991;52:118–126. - PubMed
-
- American Society of Addiction Medicine. ASAM Patient Placement Criteria for the Treatment of Substance-related Disorders. 2. Lippincott Williams & Wilkins; Chevy Chase: 2001. Revised ed.
-
- Barkham M, Stiles WB, Connell J, Twigg E, Leach C, Lucock M, Mellor-Clark J, Bower P, King M, Shapiro DA, Hardy GE, Greenberg L, Angus L. Effects of psychological therapies in randomized trials and practice-based studies. Br J Clin Psychol. 2008;47:397–415. - PubMed
-
- Bertelsen M, Jeppesen P, Petersen L, Thorup A, Øhlenschlaeger J, le Quach P, Christensen TØ, Krarup G, Jørgensen P, Nordentoft M. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness: the OPUS trial. Arch Gen Psychiatry. 2008;65(7):762–771. - PubMed
-
- Blanco C, Olfson M, Goodwin RD, Ogburn E, Liebowitz MR, Nunes EV, Hasin DS. Generalizability of clinical trial results for major depression to community samples: results from the National epidemiologic survey on alcohol and related conditions. J Clin Psychiat. 2008a;69:1276–1280. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous